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Abstract
Background: The signal recognition particle (SRP) receptor plays a vital role in co-translational
protein targeting, because it connects the soluble SRP-ribosome-nascent chain complex (SRP-
RNCs) to the membrane bound Sec translocon. The eukaryotic SRP receptor (SR) is a
heterodimeric protein complex, consisting of two unrelated GTPases. The SRβ subunit is an
integral membrane protein, which tethers the SRP-interacting SRα subunit permanently to the
endoplasmic reticulum membrane. The prokaryotic SR lacks the SRβ subunit and consists of only
the SRα homologue FtsY. Strikingly, although FtsY requires membrane contact for functionality,
cell fractionation studies have localized FtsY predominantly to the cytosolic fraction of Escherichia
coli. So far, the exact function of the soluble SR in E. coli is unknown, but it has been suggested that,
in contrast to eukaryotes, the prokaryotic SR might bind SRP-RNCs already in the cytosol and only
then initiates membrane targeting.
Results:  In the current study we have determined the contribution of soluble FtsY to co-
translational targeting in vitro and have re-analysed the localization of FtsY in vivo by fluorescence
microscopy. Our data show that FtsY can bind to SRP-ribosome nascent chains (RNCs) in the
absence of membranes. However, these soluble FtsY-SRP-RNC complexes are not efficiently
targeted to the membrane. In contrast, we observed effective targeting of SRP-RNCs to
membrane-bond FtsY. These data show that soluble FtsY does not contribute significantly to
cotranslational targeting in E. coli. In agreement with this observation, our in vivo analyses of FtsY
localization in bacterial cells by fluorescence microscopy revealed that the vast majority of FtsY was
localized to the inner membrane and that soluble FtsY constituted only a negligible species in vivo.
Conclusion: The exact function of the SRP receptor (SR) in bacteria has so far been enigmatic.
Our data show that the bacterial SR is almost exclusively membrane-bound in vivo, indicating that
the presence of a soluble SR is probably an artefact of cell fractionation. Thus, co-translational
targeting in bacteria does not involve the formation of a soluble SR-signal recognition particle
(SRP)-ribosome nascent chain (RNC) intermediate but requires membrane contact of FtsY for
efficient SRP-RNC recruitment.
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Background
The signal recognition particle (SRP) dependent targeting
constitutes a universally conserved protein targeting path-
way that ensures the co-translational delivery of substrates
to the membrane-bound Sec translocon [1]. Co-transla-
tional targeting is achieved because SRP recognizes its
cargo early in translation [2,3]. Subsequently, the SRP-
ribosome nascent chain complex (SRP-RNC) is targeted to
the membrane-bound SRP receptor (SR) [4,5], which in
eukaryotes is composed of two GTPase subunits. SRα is
tethered to the ER membrane via the membrane integral
SRβ subunit and is responsible for binding the SRP-RNC.
However, SRβ is not only required for the anchoring of
SRα to the membrane, it is also involved in coordinating
the transfer of the RNC to the Sec translocon [6,7].
Despite its conservation, the SRP-dependent targeting in
bacteria such as Escherichia coli deviates from the eukaryo-
tic pathway because, here, SRP delivers almost exclusively
inner membrane proteins, while secretory proteins are tar-
geted by the post-translational SecA/SecB pathway [1]. In
addition, the bacterial SR consists of only the SRα homo-
logue FtsY, but lacks a membrane-integral SRβ subunit.
However, FtsY can bind to the E. coli membrane via two
lipid-binding helices, one located at the N-terminus of
FtsY and a second at the interface between the non-essen-
tial A-domain and the essential N-domain [8,9]. Deleting
both lipid-binding helices prevents targeting [9-11],
which supports data showing that only membrane-bound
FtsY is able to induce efficient dissociation of SRP from
the RNC [12]. FtsY also contacts the Sec translocon
directly [10,13,14], suggesting that in bacteria a single
polypeptide is sufficient for the binding of SRP-RNCs to
the membrane and for coordinating their transfer to the
Sec translocon.
Despite the importance of the FtsY-membrane interac-
tion, in cell fractionation studies about 60% of FtsY were
found in the cytosolic cell fraction and only 40% at the
membrane [15]. However, the function of the soluble FtsY
is still largely enigmatic. Despite its inability to induce
SRP release from the RNCs, in vitro data have shown that
soluble FtsY is able to associate with SRP in the absence of
membranes [16-20] and that the presence of RNCs
strongly accelerates the FtsY-SRP complex formation in
solution [21]. These data are consistent with a model in
which FtsY binds to SRP-RNCs already in the cytosol and
then targets the SRP-RNC complex to the membrane [22].
Nevertheless, the formation of a soluble FtsY-SRP-RNC
complex is probably not a prerequisite for cotranslational
targeting in bacteria, because FtsY derivatives which are
permanently membrane-tethered via a transmembrane
domain are functional in vivo [23].
In the current study we have analysed the contribution of
soluble FtsY to cotranslational targeting in vitro and found
that, although FtsY can bind to SRP-RNCs in solution,
these soluble FtsY-SRP-RNC complexes were not effi-
ciently targeted to the membrane. Furthermore, we re-
examined the localization of FtsY in vivo by fluorescence
microscopy and found it almost exclusively located at the
cytoplasmic membrane.
Results and discussion
Soluble FtsY binds to SRP-ribosome nascent chains but is 
unable to efficiently target them to the membrane
The presence of a predominantly soluble SRP receptor in
bacteria has led to the hypothesis that FtsY binds to SRP-
RNCs already in the cytosol and then targets the SRP-
RNCs to the membrane [22]. Several studies have shown
that FtsY is able to interact with SRP or SRP-RNCs in solu-
tion, that is, in the absence of membranes [16-21]. How-
ever, whether FtsY-SRP-RNC complexes which were
assembled in the absence of membranes are efficiently tar-
geted to the membrane, has not so far been analysed.
For addressing this crucial question we employed a puri-
fied  in vitro transcription/translation system. In a first
approach we analysed whether binding of FtsY to RNCs in
the absence of membranes was also observed in this in
vitro system. RNCs of the SRP-dependent membrane pro-
tein mannitol permease (MtlA) were in vitro synthesized
in the presence of SRP and incubated with either purified
in vitro synthesized FtsY or a buffer. RNCs were then iso-
lated by centrifugation through a sucrose cushion and the
supernatant (containing unbound FtsY) and the pellet
fractions (containing RNCs and bound FtsY) were sepa-
rated on SDS polyacrylamide gel (SDS-PAGE). Phosphor
imaging revealed that the 189 amino acid long RNCs of
MtlA (MtlA-189 RNCs) were almost exclusively found in
the pellet fraction after centrifugation (Figure 1). How-
ever, we observed only a weak binding of purified 35S-
labelled FtsY to these SRP-RNCs, unless the non-hydrolys-
able GTP-analogue guanosine 5'(β,-ν imido) triphosphate
(GMP-PNP) was added. This was not the result of a GMP-
PNP induced aggregation of FtsY, because, after adding
puromycin to dissociate the ribosome, almost 100% of
both FtsY and MtlA-189 were found in the supernatant
(Figure 1). The addition of GMP-PNP has been shown to
stabilize the FtsY-SRP interaction in vitro [18]. In agree-
ment with previously published data [18], the binding of
FtsY to MtlA-189 RNCs was only observed in the presence
of SRP (data not shown). Thus, these in vitro data confirm
that FtsY cannot bind directly to RNCs but only via an
SRP.
The ability of FtsY to bind to SRP-RNC complexes in the
absence of membranes would support the hypothesis that
FtsY binds to its cargo already in the cytosol, and then tar-
gets it to the membrane. Flotation gradient analyses have
been successfully used to determine the membrane target-
ing of RNCs, because this approach allows the differenti-BMC Biology 2009, 7:76 http://www.biomedcentral.com/1741-7007/7/76
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ation between RNCs that were targeted to the SecYEG-
containing membrane fractions of the gradient (fractions
2 and 3) and those that were not targeted or aggregated
(fractions 4 and 5) [24,25]. MtlA-189 RNCs were in vitro
synthesized in the presence of purified SRP and subjected
to flotation gradient centrifugation. In the absence of
inner membrane vesicles (INV), almost 100% of the
MtlA-189 RNCs were found in the pellet fraction of the
gradient, but in the presence of wild-type INV almost 75%
of the RNCs were bound to the membrane (Figure 2A).
For analysing the contribution of FtsY to membrane tar-
geting, we employed INV derived from the E. coli strain
IY28. In this strain, the expression of FtsY is under the con-
trol of the arabinose promoter which allows the gradual
depletion of FtsY by growing cells without arabinose. In
comparison to wild-type INV, targeting of MtlA-189 RNCs
to FtsY-depleted IY28 INV was significantly reduced (Fig-
ure 2A), but was almost fully restored when purified FtsY,
together with the MtlA-189 RNCs, was added to the FtsY-
depleted INVs (Figure 2A).
By adding purified FtsY and the RNCs to FtsY-depleted
INV, we were unable to distinguish between targeting that
involves the formation of soluble FtsY-SRP-RNC com-
plexes and targeting that is achieved because FtsY binds to
the membrane first and only then accepts the SRP-RNCs.
We therefore incubated FtsY-depleted IY28 INV with puri-
fied FtsY and re-isolated these reconstituted INV by cen-
trifugation before adding the MtlA-189 RNCs. Flotation
gradient analyses revealed significant targeting of MtlA-
189 RNCs to the reconstituted IY 28 INV (Figure 2B).
Western blotting confirmed that FtsY was almost undetec-
table in FtsY-depleted INV (Figure 2C) and revealed that
the FtsY content of the reconstituted IY28 INV was com-
parable to that of wild-type INV (Figure 2C). Antibodies
against the membrane protein YidC were used as a control
in order to ensure that comparable amounts of protein
were loaded (Figure 2C). As the in vitro transcription/
translation system used in these experiments does not
contain soluble FtsY ([26], Figure 2D), these data demon-
strate that the formation of a soluble FtsY-SRP-RNC com-
plex is obviously not essential for efficient targeting.
Although the co-sedimentation assays (Figure 1) indi-
cated that FtsY can form stable complexes with SRP-RNCs
in the presence of GMP-PNP, it is currently unknown
whether these soluble FtsY-SRP-RNC complexes are tar-
geted to the membrane. We, therefore, in vitro synthesized
MtlA-189 RNCs in the presence of SRP and subsequently
incubated these SRP-RNCs with purified FtsY in the pres-
ence of GMP-PNP. The non-bound FtsY was then
removed by centrifugation of the RNCs through a sucrose
cushion and binding of FtsY to the SRP-RNCs was ana-
lysed by immune precipitation. MtlA-189 RNCs that were
synthesized in the absence of SRP were precipitated by
trichloroacetic acid (TCA) but not by antibodies against
Ffh or FtsY (Figure 3A). If the synthesis was performed in
the presence of SRP, α-Ffh antibodies, but not α-FtsY or
pre-immune serum (Pre-IS), precipitated the MtlA189
RNCs, demonstrating that SRP was bound to these RNCs.
When the SRP-MtlA189-RNCs were incubated with FtsY,
immune precipitation was also achieved with α-FtsY anti-
bodies, indicating the formation of FtsY-SRP-MtlA-189
RNC complexes in solution. In the absence of SRP, FtsY
was unable to bind to RNCs, which, again, demonstrates
that FtsY obviously does not bind directly to RNCs but
only via SRP.
The targeting of the SRP-MtlA-189 RNC complexes and
the FtsY-SRP-MtlA-189 RNC complexes was then analysed
using flotation gradient analyses. Efficient targeting of
SRP-MtlA-189 RNCs was observed only when membrane-
bound FtsY was present - for example, in the presence of
wild-type INV or FtsY-reconstituted IY28 INV - but not
with FtsY-depleted IY28 INV (Figure 3B). Strikingly, we
did not observe efficient targeting of soluble FtsY-SRP-
MtlA-189 RNCs complexes to FtsY-depleted IY28 INV
(Figure 3B). Although a complex formation between FtsY
Binding of FtsY to ribosome nascent chains requires the  presence of signal recognition particles (SRP) and guanosine  5'(β,-γ imido) triphosphate (GMP)-PNP Figure 1
Binding of FtsY to ribosome nascent chains requires 
the presence of signal recognition particles (SRP) and 
guanosine 5'(β,-γ imido) triphosphate (GMP)-PNP. 
MtlA189 RNCs were in vitro synthesized in the presence of 
purified SRP and in vitro synthesized, purified FtsY. When 
indicated puromycin or GMP-PNP were added. Ribosome-
nascent chains (RNCs) were subsequently separated by cen-
trifugation through a sucrose cushion into pellet fraction (P) 
and supernatant (S), which were analysed on SDS-polyacryla-
mide gel electrophoresis (SDS-PAGE). Both panels of the fig-
ure correspond to the same gel but were separated due to 
the large size-difference between FtsY and the RNCs. The 
radioactive material was quantified using a phosphor imager 
and the Imagequant software. Three independent experi-
ments were performed.
35S-FtsY
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SP P P SS
% pellet
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FtsY-depleted inner membrane vesicles are unable to support co-translational targeting Figure 2
FtsY-depleted inner membrane vesicles are unable to support co-translational targeting. (A) MtlA189 RNCs 
were incubated with wild-type (wt) INV, FtsY-containing IY28 INV (FtsY+) and FtsY-depleted IY28 INV (FtsY) (1 μl, 50 μg pro-
tein) and subjected to flotation gradient centrifugation. Subsequently, the gradient was separated into five fractions, which were 
analysed on SDS-PAGE. Fraction 2 and 3 of the gradient correspond to the membrane fraction, while fraction 4 and 5 reflect 
the ribosome-nascent chains that did not bind to the inner membrane vesicles [INV]. The sum of the radioactive material in all 
fractions was set as 100% and the amount of radioactive material in the individual fractions was quantified using a phosphor 
imager. (B) Flotation gradient analyses as in A, but FtsY-depleted IY28 INV were pre-incubated with purified FtsY (2 μg/25 μl; 
reconst. IY28). (C) Western blot analyses of the INV (5 μl; 250 μg protein) analysed in A and B using polyclonal antibodies 
against FtsY and against the integral membrane protein YidC. (D) Western blot analyses of the in vitro transcription/translation 
system used in this study using polyclonal anti-FtsY antibodies. Two equivalents of the in vitro system components were loaded. 
One equivalent corresponds to the amount required for in vitro protein synthesis. As control wild-type INV (200 μg protein) 
and purified FtsY (0.1 μg) were loaded.
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and SRP-RNCs is possible in solution, this early interac-
tion obviously does not permit the subsequent membrane
targeting. It is important to emphasize that the addition of
GMP-PNP does not prevent targeting, because GTP
hydrolysis is not required for the insertion of the signal
peptide into the translocon but rather for the dissociation
of the SRP-SR complex [20].
FtsY is predominantly membrane-localized in vivo
The inability of soluble FtsY to induce targeting is puz-
zling in light of biochemical data which have localized
more than 60% of FtsY to the cytosol in E. coli [15]. This
latter study used freezing/thawing cycles combined with
ultrasonic treatment for cell breakage. In order to analyse
whether the distribution of FtsY was influenced by the
method used for cell breakage, we employed a different
technique - a French pressure cell. Using the standard pro-
tocol, at least 50% of FtsY were present in the cytosolic
fraction (Figure 4A). However, under these conditions a
significant portion of the integral membrane protein YidC
was also still detectable in the supernatant. Using pro-
longed centrifugation times (up to 4.5 h) led to the almost
complete sedimentation of YidC and also to a significant
sedimentation of the soluble protein Hsp60. In contrast,
even under these conditions, FtsY was largely present in
the supernatant (Figure 4a).
The in vitro data demonstrated that soluble FtsY does not
contribute significantly to co-translational targeting and
so it is possible that soluble FtsY is involved in processes
Soluble FtsY- signal recognition particle (SRP) - MtlA189 ribosome-nascent chains (RNCs) are not efficiently targeted to inner  membrane vesicles Figure 3
Soluble FtsY- signal recognition particle (SRP) - MtlA189 ribosome-nascent chains (RNCs) are not efficiently 
targeted to inner membrane vesicles. (A) In vitro synthesized MtlA189 RNCs were incubated with purified SRP, FtsY or 
both in the presence of guanosine 5'(β,-γ imido) triphosphate (GMP)-PNP. The RNCs were subsequently isolated by centrifu-
gation through a sucrose cushion and resuspended in buffer (50 mM triethanolamine acetate, pH 8; 50 mM potassium acetate; 
5 mM magnesium acetate; 1 mM DTT). One volume was directly trichloroacetic acid precipitated and five volumes were sub-
jected to immune precipitation using sepharose-bound polyclonal antibodies against either Ffh or FtsY. As control pre-immune 
serum (Pre-IS) was used. (B) The MtlA189 RNCs shown in A, and containing either SRP or SRP and FtsY, were incubated with 
the indicated inner membrane vesicles (1 μl, 50 μg protein) and subjected to flotation gradient centrifugation.
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other than SRP-dependent targeting. This could also
explain the vast excess of FtsY over SRP (10.000 molecules
FtsY versus 100 molecules Ffh/E. coli cell) [27]. Alterna-
tively, because FtsY is only peripherally attached to the
membrane [8,11], it is also conceivable that during cell
breakage a significant fraction of FtsY is detached from the
membrane. We therefore analysed the distribution of FtsY
in E. coli by non-invasive fluorescence microscopy using
an FtsY derivative with a C-terminally fused GFP-(green
fluorescent protein) tag. The functionality of this con-
struct was confirmed by testing its ability to suppress the
growth defect of IY28 cells. These cells, carrying only the
arabinose-inducible endogenous ftsY gene, are unable to
grow on fructose-containing plates (Figure 4B). However,
expressing plasmid-borne copies of wild-type FtsY, or of
the FtsY-GFP construct, in trans restored growth com-
pletely (Figure 4B). As a control, we also fused GFP to the
C-terminus of the FtsY mutants FtsY(B3) and FtsY(NG+1).
Both FtsY derivatives carry mutations/deletions in the
lipid-binding domains of FtsY and show reduced mem-
brane binding [9,28]. As a result, they are only partially
active and were unable to completely restore the growth of
IY28 on fructose media, despite their higher expression
level in comparison to endogenous FtsY (Figure 4C)
When FtsY-GFP was expressed in wild-type E. coli and ana-
lysed by fluorescence microscopy, it was predominantly
localized to the membrane (Figure 5A). A three dimen-
sional de-convolution of Z-stacks of FtsY-GFP confirmed
that there is little to no FtsY within the cytosol of E. coli.
Quantifying the fluorescent signals revealed that more
than 80% of FtsY were associated with the cell membrane
(Figure 5A, Additional file 1). Considering that, even after
de-convolution, the signal in the cytosol is influenced by
the fluorescence of the distal and proximal membranes,
the amount of membrane-bound FtsY is most likely to be
even higher. In order to exclude the possibility that the
presence of the GFP-tag favoured the exclusive membrane
localization of FtsY, we analysed the localization of
FtsY(NG+1)-GFP and FtsY(B3)-GFP. These FtsY deriva-
tives were uniformly distributed throughout the whole E.
coli cell, - that is, they were present both at the membrane
and in the cytosol - which is in agreement with their
reduced ability to bind to the E. coli membrane [9,28]
(Figure 5A, Additional files 2 and 3). Although we consid-
ered it unlikely that the predominant membrane localiza-
tion of FtsY was the result of the higher expression-level of
the GFP-constructs in comparison to the endogenous FtsY
(Fig. 4C), we also analysed the localization of the endog-
enous FtsY in wild-type E. coli cells by immune-fluores-
cence, using fluorescently labelled antibodies against α-
FtsY IgGs. This approach confirmed that the endogenous,
non-tagged FtsY was also almost exclusively localized to
the inner membrane of E. coli (Figure 5B). The localiza-
tion of FtsY was not significantly different from the local-
ization of the integral membrane protein SecY (Figure
5B).
In E. coli and other proteobacteria, membrane localiza-
tion of FtsY is mainly achieved via two cooperating lipid
binding domains; in Gram positive bacteria and archaea,
FtsY contains either a true transmembrane helix or a sin-
gle, but extended, lipid-binding helix [29-31]. We there-
fore analysed the localization of FtsY also in the Gram
positive bacterium Bacillus subtilis by creating a C-terminal
YFP (yellow fluorescent protein) fusion. B. subtilis cells
expressing only the FtsY-YFP fusion from the original gene
locus were viable, indicating that FtsY-YFP was a func-
tional substitute of the essential endogenous FtsY [29].
Unlike E. coli FtsY, B. subtilis FtsY formed defined foci
along the lateral cell membrane (Figure 5C, indicated by
white triangle), and occasionally at the cell poles (in 20%
of the cells showing defined signals). We did not detect
FtsY foci in about 25% of all cells, probably because they
were too faint. Fluorescence within the cytosol was similar
to background fluorescence in cells lacking any YFP
fusion, showing that, despite the differences in the mode
of membrane binding between E. coli FtsY and B. subtilis
FtsY, the latter is also highly enriched at the cytoplasmic
membrane (Figure 5C).
So far, the function of soluble FtsY in E. coli and other
prokaryotes has been mysterious, and our data now dem-
onstrate that soluble FtsY represents only a minor species
in vivo. The high amount of soluble FtsY observed after
cell fractionation is most likely to be an artefact of cell
breakage. Thus, the exclusive membrane localization of
FtsY/SRα appears to be an evolutionary conserved feature,
although the exact mechanisms of tethering FtsY/SRα to
the membrane are different. In eukaryotes, it is mainly
achieved via the protein-protein contact to SRβ, while in
prokaryotes, protein-lipid contact is dominating [8,9,11].
These differences in the mode of membrane binding also
explain why only the SRP- and GTP-interacting NG
domains of FtsY/SRα are highly conserved, while the low
conserved N-terminal domains are adapted to their partic-
ular mode of membrane binding.
The predominant membrane localization of FtsY in bacte-
ria also mitigates an otherwise crucial obstacle to the bac-
terial SRP cycle: if SRP and FtsY interacted efficiently with
each other in the cytosol, they would probably undergo
futile cycles of GTP hydrolysis. To prevent this, FtsY-SRP
complex formation or stability should respond to cargo
loading. Kinetic studies have demonstrated that the for-
mation of the SRP-SR complex is slow in the absence of
RNCs [4,21,32,33]. However, even in the presence of
cargo, significant GTP hydrolysis and complex dissocia-
tion is observed in the solution [21]. Thus, to prevent
futile GTP hydrolysis, the GTPase cycle should also
respond to the presence of membranes. A recent study hasBMC Biology 2009, 7:76 http://www.biomedcentral.com/1741-7007/7/76
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Cellular localization of FtsY in vitro and in vivo Figure 4
Cellular localization of FtsY in vitro and in vivo. (A) Escherichia coli cells were grown on LB medium up to mid-exponential 
phase (OD600 1.2). Cell breakage was performed using a French pressure cell in the presence of protease inhibitors. Unbroken 
cells and large cell fragments were removed by centrifugation and the supernatant of this centrifugation was then separated by 
ultracentrifugation into the soluble fraction (S) and the pellet fraction (P). Conditions indicate the centrifugation time in a 
Ti50.2 rotor at 45,000 rpm. After western transfer, the different fractions were analysed using antibodies against FtsY, against 
the integral membrane protein YidC and against the soluble protein Hsp60 (GroEL). (B) The functionality of the FtsY-green flu-
orescent protein (GFP) constructs was analysed by expressing plasmid-borne copies in the conditional FtsY depletion strain 
IY28. IY 28 containing either no plasmid (IY28) or the indicated plasmids was grown on LB-plates in the presence or absence of 
arabinose. Wt FtsY corresponds to untagged FtsY, wt FtsY-GFP corresponds to full length FtsY fused C-terminally to GFP. 
FtsY(B3)-GFP and FtsY(NG+1)-GFP correspond to GFP-tagged FtsY mutants which exhibit reduced activity due to impaired 
membrane binding. The growth experiments were performed in the absence of IPTG for preventing high-level expression of 
the plasmid-borne FtsY derivatives. (C) Western blot analyses of IY28 cells containing either no or the indicated plasmids. 
Cells were grown in the presence of arabinose or fructose but in the absence of IPTG.
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FtsY is predominantly membrane bound in vivo Figure 5
FtsY is predominantly membrane bound in vivo. (A) Wild-type Escherichia coli cells carrying different FtsY-green fluores-
cent protein derivatives as described in Figure. 4 were analysed by fluorescence microscopy. The upper panel displays the orig-
inal image and the lower panel a processed image after a three dimensional deconvolution of Z-stacks. (B) The localization of 
FtsY and the integral membrane protein SecY were analysed in wild-type E. coli cells containing only the endogenous amounts 
of FtsY and SecY. For this purpose, immune-fluorescence was carried out using polyclonal SecY and FtsY antibodies and Alexa 
fluor 555 labelled secondary antibodies. (C) Bacillus subtilis cells expressing FtsY-YFP as sole source of the protein growing 
exponentially; foci along the lateral cell membrane are indicated by white triangle. White bar 2 μm.
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shown that mutating the lipid binding domain in chloro-
plast FtsY results in the loss of membrane-induced GTPase
stimulation and higher rates of GTP hydrolysis in solution
[34]; a similar link between GTP hydrolysis and mem-
brane binding has also been proposed in E. coli [35].
Biochemical data have shown that FtsY binds preferen-
tially to negatively charged phospholipids [8,11,35] and
at least transiently to the SecY translocon [10,13,14]. Due
the limited number of SecYEG translocons (300-500/E.
coli  cell, [27]), the exclusive membrane localization of
FtsY suggests that in vivo FtsY is mainly bound to phos-
pholipids. However, this probably excludes phospholip-
ids as major player in regulating co-translational protein
targeting in bacteria. Instead, the FtsY-translocon contact
might be the key element in controlling the GTPase cycle
and the insertion of the substrate into the translocation
channel. In eukaryotes, the GTPase domain of the SRβ
subunit appears to be crucial for the coordination of RNC
binding with the subsequent transfer to the Sec translocon
[4,6,7,36]. As FtsY can directly interact with the SecYEG
translocon [10,13,14], the SRP receptor in prokaryotes
can probably mediate both functions: binding of the SRP-
RNCs and coordinating their transfer to the Sec translo-
con.
So far, the kinetic analyses of the bacterial SRP cycle have
only been performed in the absence of membranes and,
in some cases, with N-terminal truncated FtsY derivatives
lacking at least the first lipid-binding domain
[20,21,37,38]. Although these studies have provided a
wealth of important information about the SRP cycle, it is
essential to determine the impact of membranes and the
Sec translocon on the kinetics of the SRP cycle in future
studies. Finally, our data also show that, although FtsY can
bind to SRP-RNCs, in solution it fails to efficiently target
these SRP-RNCs to the membrane. It seems likely that the
interaction of FtsY with SRP-RNCs in solution interferes
with the subsequent binding of FtsY to lipids or SecY,
although this needs to be confirmed. Nevertheless, con-
sidering that soluble FtsY obviously represents only a
minor species in E. coli, its low targeting activity should
not impose any problems for the cell.
Conclusion
The prokaryotic SRP receptor lacks a membrane-integral
SRβ  subunit and has been mainly localized to the
cytosolic cell fraction after cell breakage. This predomi-
nant cytosolic localization has been taken as an indication
that, in bacteria, the SRP receptor interacts with the SRP-
RNCs already in the cytosol and then targets them to the
membrane. Our in vivo data now show that, despite the
lack of a SRβ subunit, FtsY is almost exclusively mem-
brane bound in bacteria and that targeting of SRP-RNCs is
only possible when FtsY is membrane-bound. Thus, the
exclusive membrane localization of FtsY/SRα appears to
be an evolutionary conserved feature, although the exact
mechanisms of tethering FtsY/SRα to the membrane are
different between prokaryotes and eukaryotes.
Methods
Strains, plasmids, cell growth and fractionation methods
The following E. coli strains were used: Bl21, MRE 600
[39], TY0 [40] and IY28 (obtained from Eitan Bibi). The
conditional FtsY-depletion strain IY28 was routinely
grown on LB medium supplemented with 0.4% arab-
inose. For FtsY-depletion, IY28 was grown overnight on
media supplemented with 0.2% arabinose. After harvest-
ing the cells by centrifugation, cells were washed twice
with media lacking arabinose and used to inoculate cul-
tures containing either 0.2% arabinose to induce FtsY
expression or 0.2% fructose for FtsY depletion. Growth
was monitored by measuring the optical density at 600
nm. For in vitro protein synthesis the following plasmids
were used: pKSM717-MtlA (MtlA) [26], pTP37 (FtsY) [41]
and pET19b-Ffh [42]. For FtsY-GFP fusions, FtsY was PCR
amplified using pTP37 as template and ligated into
pTrc99a using NcoI and BamHI restriction, resulting in
plasmid pTrc99a-FtsY. pTrc99a-FtsY was then digested
with HindIII and the100 bp HindIII fragment (containing
the C-terminal His Tag and the stop codon of FtsY) was
replaced by a 754 bp long polymerase chain reaction
(PCR) product containing the GFP. This PCR product was
generated by using the plasmid pCA24NCycY-GFP
(National Bioresource Project Japan) and the primer FtsY-
GFPfw (5'-GAAACAGTCAAGCTTC-GCGGCC-3') and
FtsY-GFPrev (5'-CCTGCAGCCA-AGCTTAATTAGCT-3').
The construction of the FtY(B3) and FtsY NG+1 GFP
fusions followed the same strategy, with the exception
that the first PCR was performed with pSAFtsY(NG+1)
[14] or pTP37-FtsYB3 [9] as templates.
In order to generate an FtsY-YFP fusion in B. subtilis, the
last 500 bp of the ftsY gene were amplified by PCR and
were cloned into plasmid pSG1164y [43] using ApaI and
EcoRI restriction sites. B. subtilis PY79 was transformed
with the resulting plasmid, selecting for chloramphenicol
resistance, leading to an integration of the plasmid into
the chromosome at the ftsY  locus. All chemicals and
growth media components were obtained from Roth
(Karlsruhe, Germany) unless otherwise stated.
For cell fractionation, E. coli cells were grown in INV
medium at 37°C up to an OD600 of 1.2. After harvesting,
the cells were resuspended in buffer A (50 mM trieth-
anolamine acetate, pH 7.5, 0.25 M sucrose, 1 mM EDTA,
1 mM DTT, 5 ml/1 g cells) and broken by three passages
through a French Pressure Cell at 8000 psi in the presence
of phenylmethylsulfonyl fluoride (1 mM) and Complete-
EDTA-free protease inhibitor (Roche, Mannheim, Ger-
many). Unbroken cells and large cell debris were removed
by centrifugation for 30 min at 5000 rpm in a SS34 rotorBMC Biology 2009, 7:76 http://www.biomedcentral.com/1741-7007/7/76
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(Kendro-Sorvall, Langenselbold, Germany). The superna-
tant was then subjected to an ultracentrifugation step to
separate the membrane fraction from the soluble fraction.
The standard protocol included a centrifugation at 45,000
rpm in a Ti50.2 rotor (Beckman-Coulter, Krefeld, Ger-
many) for 2.5 h at 4°C. The membrane pellet was resus-
pended in INV buffer (buffer A without EDTA).
In vitro synthesis
The in vitro synthesis of RNCs and flotation gradient anal-
yses of membrane-bound RNCs were performed (as
described in [24-26]). For flotation gradients, 1 μl of INV
(50 μg protein) were incubated with a 50 μl in vitro reac-
tion mixture. For sedimentation assays, 50 μl RNCs were
pelleted through a sucrose cushion (100 μl, 40 mM trieth-
anolamine acetate, pH 7.5; 70 mM potassium acetate; 10
mM magnesium acetate, 1 mM DTT and 580 mM sucrose)
for 60 min at 90,000 rpm in a Beckmann 100.2 rotor. In
vitro  synthesized FtsY and Ffh were purified via Talon
metal affinity resin (as described in [14]) before incuba-
tion with RNCs. SRP was reconstituted by incubating puri-
fied Ffh and purified 4.5S RNA in a 1:2 ratio for 15 min at
25°C [37]. For reconstituting SRP with in vitro synthesized
Ffh, 35S-labelled Ffh was incubated with 1 μg of 4.5S RNA
as described above and then purified via Talon metal
affinity resin. FtsY, Ffh and 4.5S RNA were purified (as
described in [24,42]). Immune precipitation was per-
formed in fivefold scaled-up reactions using polyclonal
rabbit antibodies against FtsY and Ffh, covalently linked
to protein A-sepharose matrix [24]. Radioactively labelled
proteins were separated on 13% SDS-polyacrylamide gels
and visualized using a phosphorimager. The radioactive
material was quantified using the Imagequant software
(GE Healthcare, Munich, Germany).
Fluorescence microscopy and immune fluorescence
In order to investigate GFP-tagged proteins, bacterial cells
were immobilized on a microscope slide with low melting
agarose. For immune fluorescence, E. coli cells were grown
to exponential phase (OD600~0.8 to 1.2) in LB medium
supplemented with the appropriate antibiotics and 0.4%
arabinose. Five hundred microlitres of culture were fixed
with 100 μl 16% paraformaldehyde in phosphate buff-
ered saline (PBS, 10 mM Na2HPO4/NaH2PO4, 150 mM
NaCl, 3 mM KCl, pH 7.4) with 0.125% glutardialdehyde
for 15 min at room temperature and afterwards for an
additional 30 min on ice. Following three washing steps
with PBS, cells were resuspended in 500 μl GTE buffer (50
mM glucose, 10 mM EDTA, 20 mM Tris pH 7.5). Lys-
ozyme was added to a final concentration of 2 μg/ml and
an appropriate amount of the cell suspension was directly
applied to the wells of an eight-well microscope slide
(Thermo Scientific, Braunschweig, Germany) coated with
Poly-L-Lysine (Sigma Aldrich, Steinheim; Germany). After
5 min of incubation, the excess cells were removed using
a vacuum pump and the wells were washed once with
PBS. The samples were then blocked with 2% bovine
serum albumine in PBS for 15 min at room temperature.
Primary antibodies (rabbit-raised polyclonal anti-FtsY or
anti-SecY anti-serum) in 2% BSA/PBS were added directly
afterwards and incubated over night at 4°C. The dilution
yielding the best results was determined by titration for
each antibody independently. The next-day samples were
washed 10 times with PBS and, subsequently, an Alexa
Fluor 555 coupled goat anti-rabbit antibody (Invitrogen;
Karlsruhe, Germany) was added at a final concentration
of 4 μg/ml in 2% BSA/PBS. After incubation for 90 min in
the dark at room temperature and washing with PBS, the
samples were dried, an appropriate amount of SlowFade
Gold (Invitrogen, Karlsruhe, Germany) was applied and
the slide was covered with microscope cover slips. Stained
proteins were visualized using an Olympus BX-51 fluores-
cence microscope at a 100× magnification with a numeri-
cal aperture of 1.4 and a Cy3 fluorescence filter set. Images
were acquired with a charge-coupled device camera (F-
View, Olympus, Hamburg, Germany). Z-stacks were cap-
tured on a Zeiss Axioimager Microscope with an objective
piezo. A three dimensional deconvolution was performed
using Autodeblur X software.
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